Navigation Links
Regado Biosciences to Present at the 2011 RBC Capital Markets Healthcare Conference in New York City
Date:2/23/2011

BASKING RIDGE, N.J., Feb. 23, 2011 /PRNewswire/ -- Regado Biosciences, a privately held company leading the development of antithrombotic aptamers with active control agents, announced that Ellen McDonald, MBA, Senior Vice President and Chief Business Officer, will be speaking and participating on a panel that will highlight new and innovative cardiovascular drug therapies at the 2011 RBC Capital Markets Healthcare Conference.  The panel discussion will be held at the New York Palace Hotel in New York City on Wednesday, March 2, 2011 at 2:35 p.m. EST in Holmes 1.  

ABOUT REGADO BIOSCIENCES

Regado Biosciences, Inc. is a private biopharmaceutical company pioneering a new therapeutic technology with the creation and development of proprietary controllable aptamer drug systems.  Each system comprises a nuclease-stabilized RNA aptamer, the therapeutic effect of which can be reversed partially or completely in real time by its specific and complementary oligonucleotide active control agent. This technology is being applied to injectable antithrombotics (including anticoagulants and antiplatelet agents) in the acute and sub-acute care cardiovascular setting, a multi-billion dollar world-wide market in need of drugs with improved safety profiles and a greater degree of therapeutic control.  The products in Regado's pipeline are designed to act as optimized antithrombotics, uniquely concomitantly minimizing the risk of ischemia and bleeding, and, by allowing patient specific tuning of the desired therapeutic effect, providing a safe and unique approach to personalized medicine.

ABOUT REG1, REG2 and REG3  

Regado's lead program, the anticoagulant system REG1, consists of two parenteral agents both administered by IV bolus, the first being a potent highly selective Factor IXa inhibitor (pegnivacogin, a.k.a. RB006) and the second being its complementary active control agent (anivamersen, a.k.a. RB007).  Anivamersen c
'/>"/>

SOURCE Regado Biosciences
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Regado Biosciences Initiates Phase IIa Clinical Study of REG1 Anticoagulation System
2. Regado Biosciences Presents Positive Data From REG1 Anticoagulation System Phase Ic Study at American Heart Association 2007 Scientific Sessions
3. Regado Biosciences Presents Early Stage Clinical Data for REG1 Anticoagulation System at American Heart Association 2007 Scientific Sessions
4. Regado Biosciences Announces Publication in Circulation of Clinical Trial Results of REG1 Anticoagulation System
5. Regado Biosciences Reports Clinical Results for REG1 Anticoagulation System at European Society of Cardiology Congress 2008
6. Regado Biosciences Completes Patient Enrollment for Phase IIa Study of REG1 Anticoagulation System
7. Regado Biosciences Releases Positive Phase 2a Data for the Reversible Anticoagulant System REG1 at the European Society of Cardiology Congress In Barcelona, Spain
8. Regado Biosciences to Present at the Ninth Annual Joint Symposium of BioNJ and Pennsylvania Bio on November 17, 2009
9. Regado Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference on December 1, 2009
10. Regado Biosciences, Inc. Introduces REG2, Its Second Product Candidate, at the American College of Cardiology Conference, 59th Annual Scientific Session, in Atlanta, Georgia on March 15, 2010
11. Regado Biosciences to Present at the 2010 Wells Fargo Healthcare Conference on June 24, 2010 in Boston, Massachusetts
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2015)... March 30, 2015  RXi Pharmaceuticals Corporation (NASDAQ: ... discovering and developing innovative therapeutics primarily in the ... medical needs, today reported its financial results for ... 2014, and provided a business update. ... "The past year has seen a steady growth ...
(Date:3/30/2015)...  Confirming its investment in the area of ... of Darmstadt,s announcement on the launch of the ... German government. Directed at developing ... as way to protect and prevent the brain ... anti-inflammatory and antioxidant activities of olive polyphenols, especially ...
(Date:3/29/2015)... 2015  Three-month paliperidone palmitate, an investigational atypical ... placebo in patients with schizophrenia, according to a ... in the Journal of the American ... Results of the study served as the basis ... for three-month paliperidone palmitate injection to treat schizophrenia ...
Breaking Medicine Technology:RXi Pharmaceuticals Reports Fourth Quarter and Year End 2014 Financial Results and Recent Corporate Highlights 2RXi Pharmaceuticals Reports Fourth Quarter and Year End 2014 Financial Results and Recent Corporate Highlights 3RXi Pharmaceuticals Reports Fourth Quarter and Year End 2014 Financial Results and Recent Corporate Highlights 4RXi Pharmaceuticals Reports Fourth Quarter and Year End 2014 Financial Results and Recent Corporate Highlights 5RXi Pharmaceuticals Reports Fourth Quarter and Year End 2014 Financial Results and Recent Corporate Highlights 6RXi Pharmaceuticals Reports Fourth Quarter and Year End 2014 Financial Results and Recent Corporate Highlights 7RXi Pharmaceuticals Reports Fourth Quarter and Year End 2014 Financial Results and Recent Corporate Highlights 8RXi Pharmaceuticals Reports Fourth Quarter and Year End 2014 Financial Results and Recent Corporate Highlights 9RXi Pharmaceuticals Reports Fourth Quarter and Year End 2014 Financial Results and Recent Corporate Highlights 10CreAgri Reaffirms Its Commitment to Neuroprotection and Alzheimer's Prevention in Light of German Research Project 2CreAgri Reaffirms Its Commitment to Neuroprotection and Alzheimer's Prevention in Light of German Research Project 3New Study Published in JAMA Psychiatry Found Three-Month Paliperidone Palmitate Significantly Delayed Time to Relapse in Patients with Schizophrenia 2New Study Published in JAMA Psychiatry Found Three-Month Paliperidone Palmitate Significantly Delayed Time to Relapse in Patients with Schizophrenia 3New Study Published in JAMA Psychiatry Found Three-Month Paliperidone Palmitate Significantly Delayed Time to Relapse in Patients with Schizophrenia 4New Study Published in JAMA Psychiatry Found Three-Month Paliperidone Palmitate Significantly Delayed Time to Relapse in Patients with Schizophrenia 5New Study Published in JAMA Psychiatry Found Three-Month Paliperidone Palmitate Significantly Delayed Time to Relapse in Patients with Schizophrenia 6New Study Published in JAMA Psychiatry Found Three-Month Paliperidone Palmitate Significantly Delayed Time to Relapse in Patients with Schizophrenia 7New Study Published in JAMA Psychiatry Found Three-Month Paliperidone Palmitate Significantly Delayed Time to Relapse in Patients with Schizophrenia 8New Study Published in JAMA Psychiatry Found Three-Month Paliperidone Palmitate Significantly Delayed Time to Relapse in Patients with Schizophrenia 9New Study Published in JAMA Psychiatry Found Three-Month Paliperidone Palmitate Significantly Delayed Time to Relapse in Patients with Schizophrenia 10New Study Published in JAMA Psychiatry Found Three-Month Paliperidone Palmitate Significantly Delayed Time to Relapse in Patients with Schizophrenia 11New Study Published in JAMA Psychiatry Found Three-Month Paliperidone Palmitate Significantly Delayed Time to Relapse in Patients with Schizophrenia 12
... 2011 Reportlinker.com announces that a new market research ... The 2011 US Coagulation Market ... comprehensive analysis of the US coagulation market, including: ... practice, as well as key economic, regulatory, demographic, social ...
... Mobile Dog Heart Health Tour is heading to Jacksonville for ... Johns Town Center from 11 a.m. to 3 p.m. on ... screenings in a soundproof medical unit, as well as educate ... http://photos.prnewswire.com/prnh/20110127/CG37742 ) Since early 2009, veterinarians on the ...
Cached Medicine Technology:Reportlinker Adds The 2011 US Coagulation Market 2Free Dog Heart Checks in Jacksonville 2Free Dog Heart Checks in Jacksonville 3
(Date:3/29/2015)... (PRWEB) March 30, 2015 Over 50 ... symptoms tied to undiagnosed autoimmune, thyroid, or hormone disorders. ... disorders, has personally treated hundreds of patients dealing with ... unaware of the treatment options for their ailments. Her ... solutions to women living with fatigue, brain fog, and ...
(Date:3/29/2015)... 29, 2015 Women’s Excellence , ... Secondary to their location in Birmingham, they now ... They continue to be affiliated with Crittenton, St. ... Menopause is a normal condition that all women experience ... of the changes a woman goes through either just ...
(Date:3/29/2015)... Nashville, TN (PRWEB) March 29, 2015 ... insurance that agencies promote nationally on the web can ... of permanent life insurance quotes can now be explored ... http://quotespros.com/life-insurance.html . , Learning the differences between what ... offers can be a challenge for some men and ...
(Date:3/29/2015)... March 29, 2015 The culmination of one ... coming when the Final Four invades Lucas Oil ... has been one filled with excitement, buzzer-beaters, and of course, ... busted, superstars have been made, and future professional products have ... down to the four teams that advanced through their regional ...
(Date:3/29/2015)... (PRWEB) March 29, 2015 The ... clinical trials and research, manage data results and ... their clients reach regulation standards. Contract research organizations ... medical device manufacturing sectors. Industry operators provide clients ... to late-stage clinical research for Food and Drug ...
Breaking Medicine News(10 mins):Health News:How to Turn Mid-life into the Good Life 2Health News:Women's Excellence Affiliates with Beaumont Hospital, Treats Menopause 2Health News:Permanent Life Insurance Quotes Now Offered Through Web Search System at Insurer Website Online 2Health News:Cheap 2015 Final Four Tickets: Ticket Down Slashes Kentucky Wildcats and Wisconsin Badgers Final Four Tickets at Lucas Oil Stadium and Issues Valuable Promo Code 2Health News:Contract Research Organizations in the US Industry Market Research Report from IBISWorld Has Been Updated 2Health News:Contract Research Organizations in the US Industry Market Research Report from IBISWorld Has Been Updated 3Health News:Contract Research Organizations in the US Industry Market Research Report from IBISWorld Has Been Updated 4
... Healthy, middle-aged smokers who take the most popular smoking cessation ... of being hospitalized with a heart attack or other serious ... Hopkins-led study suggests. "People want to quit smoking to ... they,re taking a drug that increases the risk for the ...
... Phoenix, AZ, USA July 4, 2011 VisionGate, ... the early detection of lung cancer, today announced that ... its LuCED test can improve the utility of low ... detection of lung cancer in high risk individuals. ...
... News) -- Staying hydrated is critical if you,re physically active ... so you need to assess your personal sweat rate, according ... "Sweat rate is very simple to calculate: weigh yourself ... half an hour and don,t drink or use the bathroom ...
... FRIDAY, July 1 (HealthDay News) -- Preschool children need to ... the true concept of counting, according to researchers. "We ... to involve counting. It,s only when children go beyond three ... are," lead author Elizabeth Gunderson, a graduate student in psychology ...
... , FRIDAY, July 1 (HealthDay News) -- A new ... a certain type of learning remarkable staying power. Over ... face or pattern from a larger group of images. They ... practice. When they were tested again one to two years ...
... citywide study published online in today,s issue of ... disparities in the use of clot-busting drugs to treat acute ... According to the study,s results, significantly fewer black patients receive ... emergency care and the presence of medical conditions that exclude ...
Cached Medicine News:Health News:Smokers using varenicline to quit the habit at greater risk of heart attack 2Health News:IASLC: Adjunctive use of 3-D imaging system increases utility of CT lung cancer screening 2Health News:IASLC: Adjunctive use of 3-D imaging system increases utility of CT lung cancer screening 3Health News:How to Stay Hydrated in Hot Weather 2Health News:Understanding Numbers Isn't as Simple as 1, 2, 3 2Health News:When It Comes to Memory, Practice Seems to Make Perfect 2Health News:Citywide study shows racial disparities in emergency stroke treatment 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: